ERBB2 and breast cancer: Triple-negative breast cancer (TNBC), characterized by lack of expression of the estrogen (ER), progesterone (PgR), and erb-b2 receptor tyrosine kinase 2 (HER2) receptors, is a particularly problematic form of breast cancer due to aggressive growth, high recurrence rates and poor long-term survival1,2.